Granules India has informed about submission of a copy of Press Release issued by the Company for receiving the approval from US FDA for the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc., a wholly owned foreign subsidiary of the company.
The above information is a part of company’s filings submitted to BSE.